Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clause, S.
Right arrow Articles by Cosler, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clause, S.
Right arrow Articles by Cosler, L.
American Journal of Health-System Pharmacy, Vol 61, Issue 10, 1025-1031
Copyright © 2004 by American Society of Health-System Pharmacists


Articles

Conforming to HIPAA regulations and compilation of research data

SL Clause, DM Triller, CP Bornhorst, RA Hamilton, and LE Cosler


PURPOSE: A set of deidentified patient data compliant with the Health Information Portability and Accountability Act (HIPAA) was compiled, the data lost as a function of unique data elements (UDEs) were measured, and the deidentified data were tested for potential for reidentification. METHODS: After approval by the institutional review board of an integrated health system, a limited-data set was created by querying the health system's pharmacy, administrative, and financial files for patients discharged between January 1 and December 31, 2000. Using the HIPAA "safe-harbor" method, this limited-data set was converted into a deidentified-data table for future statistical analysis, and UDEs in both data sets were identified and quantified. Unique combinations of commonly available data were also identified. RESULTS: The limited-data set, representing 4,738 patient discharges, contained 810,456 UDEs in 322,657 records organized into four data tables (demographics, diagnoses, medication orders, and laboratory test results). The deidentified-data table, representing 4,722 discharges, contained 562,171 UDEs in 128 data-type columns in a single data table. About 31% of the data volume was lost. Much of the information lost was of the type that is of special interest to researchers (e.g., time between episodes of care, ages of >89 years). CONCLUSION: A study suggested that deidentified patient data with a reasonable degree of protection against reidentification were less complete than may be necessary for good research.
 



This article has been cited by other articles:


Home page
J. Am. Med. Inform. Assoc.Home page
K. El Emam and F. K. Dankar
Protecting Privacy Using k-Anonymity
J. Am. Med. Inform. Assoc., September 1, 2008; 15(5): 627 - 637.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
D. M. Triller, S. L. Clause, and R. A. Hamilton
Risk of adverse drug events by patient destination after hospital discharge
Am. J. Health Syst. Pharm., September 15, 2005; 62(18): 1883 - 1889.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Society of Health-System Pharmacists.